Birdwatch Archive

Birdwatch Note

2024-10-15 00:50:47 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

The article is a hypothetical treatment protocol, and not a trial in humans. Fenbendazole is an antiparasitic med primarily used to treat worms in animals. There is currently no conclusive scientific evidence to support its use as a cancer treatment in humans. https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure https://www.logicallyfacts.com/en/fact-check/false-no-evidence-to-prove-animal-deworming-drug-fenbendazole-can-cure-cancer https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer

Written by 91C85FEE17442EAA947F33D8525232045C7F32D45E17ABC59F893F15DE3022BB
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1845968270316249190

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1845990670122496011
  • noteId - 1845990670122496011
  • participantId -
  • noteAuthorParticipantId - 91C85FEE17442EAA947F33D8525232045C7F32D45E17ABC59F893F15DE3022BB Participant Details
  • createdAtMillis - 1728953447262
  • tweetId - 1845968270316249190
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • The article is a hypothetical treatment protocol, and not a trial in humans. Fenbendazole is an antiparasitic med primarily used to treat worms in animals. There is currently no conclusive scientific evidence to support its use as a cancer treatment in humans. https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure https://www.logicallyfacts.com/en/fact-check/false-no-evidence-to-prove-animal-deworming-drug-fenbendazole-can-cure-cancer https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer

Note Ratings

rated at rated by
2024-10-16 08:22:49 -0500 Rating Details
2024-10-16 02:17:08 -0500 Rating Details
2024-10-15 23:45:23 -0500 Rating Details
2024-10-15 22:17:03 -0500 Rating Details
2024-10-15 21:32:34 -0500 Rating Details
2024-10-15 20:10:33 -0500 Rating Details
2024-10-15 12:00:20 -0500 Rating Details
2024-10-15 11:09:14 -0500 Rating Details
2024-10-15 10:27:30 -0500 Rating Details
2024-10-15 09:07:10 -0500 Rating Details
2024-10-15 09:03:39 -0500 Rating Details
2024-10-15 08:34:16 -0500 Rating Details
2024-10-15 07:55:14 -0500 Rating Details
2024-10-15 07:12:41 -0500 Rating Details
2024-10-15 06:28:14 -0500 Rating Details
2024-10-15 06:14:20 -0500 Rating Details
2024-10-15 05:12:25 -0500 Rating Details
2024-10-15 03:13:17 -0500 Rating Details
2024-10-15 03:12:05 -0500 Rating Details
2024-10-15 02:36:11 -0500 Rating Details
2024-10-15 01:44:22 -0500 Rating Details
2024-10-15 01:35:44 -0500 Rating Details
2024-10-15 01:25:53 -0500 Rating Details
2024-10-15 01:08:49 -0500 Rating Details
2024-10-15 00:55:43 -0500 Rating Details
2024-10-15 00:29:22 -0500 Rating Details
2024-10-15 00:21:50 -0500 Rating Details
2024-10-15 00:04:47 -0500 Rating Details
2024-10-14 23:35:31 -0500 Rating Details
2024-10-14 22:53:47 -0500 Rating Details
2024-10-14 21:53:53 -0500 Rating Details
2024-10-14 21:53:24 -0500 Rating Details
2024-10-14 21:50:50 -0500 Rating Details
2024-10-14 21:40:40 -0500 Rating Details
2024-10-14 21:31:26 -0500 Rating Details
2024-10-14 21:00:46 -0500 Rating Details
2024-10-14 20:22:51 -0500 Rating Details
2024-10-14 20:14:18 -0500 Rating Details
2024-10-14 19:50:59 -0500 Rating Details
2024-11-03 00:14:06 -0500 Rating Details
2024-10-16 00:29:58 -0500 Rating Details
2024-10-15 20:31:09 -0500 Rating Details
2024-10-15 18:29:38 -0500 Rating Details
2024-10-15 16:08:50 -0500 Rating Details
2024-10-15 13:25:12 -0500 Rating Details
2024-10-15 09:17:37 -0500 Rating Details
2024-10-15 07:28:41 -0500 Rating Details
2024-10-15 06:32:53 -0500 Rating Details
2024-10-15 06:24:36 -0500 Rating Details
2024-10-15 03:06:43 -0500 Rating Details
2024-10-14 23:11:20 -0500 Rating Details
2024-10-14 22:33:08 -0500 Rating Details
2024-10-14 20:50:00 -0500 Rating Details
2024-10-14 20:28:21 -0500 Rating Details
2024-10-14 20:21:59 -0500 Rating Details
2024-10-14 20:11:49 -0500 Rating Details
2024-10-17 00:47:17 -0500 Rating Details
2024-10-15 20:20:11 -0500 Rating Details
2024-10-15 17:36:41 -0500 Rating Details
2024-10-15 15:06:41 -0500 Rating Details
2024-10-15 14:55:25 -0500 Rating Details
2024-10-15 12:56:07 -0500 Rating Details
2024-10-15 12:01:45 -0500 Rating Details
2024-10-15 11:58:20 -0500 Rating Details
2024-10-15 10:21:10 -0500 Rating Details
2024-10-15 10:20:27 -0500 Rating Details
2024-10-15 09:55:51 -0500 Rating Details
2024-10-15 09:14:52 -0500 Rating Details
2024-10-15 08:06:46 -0500 Rating Details
2024-10-15 08:06:20 -0500 Rating Details
2024-10-15 07:59:20 -0500 Rating Details
2024-10-15 07:58:53 -0500 Rating Details
2024-10-15 07:40:54 -0500 Rating Details
2024-10-15 04:55:13 -0500 Rating Details
2024-10-15 04:06:49 -0500 Rating Details
2024-10-15 01:08:16 -0500 Rating Details
2024-10-15 00:58:53 -0500 Rating Details
2024-10-14 23:45:03 -0500 Rating Details
2024-10-14 23:32:11 -0500 Rating Details
2024-10-14 22:56:16 -0500 Rating Details
2024-10-14 22:41:54 -0500 Rating Details
2024-10-14 22:39:49 -0500 Rating Details
2024-10-14 21:17:11 -0500 Rating Details
2024-10-14 20:54:27 -0500 Rating Details
2024-10-15 23:52:50 -0500 Rating Details
2024-10-15 21:35:48 -0500 Rating Details
2024-10-15 19:38:15 -0500 Rating Details
2024-10-15 16:28:06 -0500 Rating Details
2024-10-15 16:23:47 -0500 Rating Details
2024-10-15 15:48:50 -0500 Rating Details
2024-10-15 14:51:50 -0500 Rating Details
2024-10-15 09:29:10 -0500 Rating Details
2024-10-15 09:12:53 -0500 Rating Details
2024-10-15 07:13:54 -0500 Rating Details
2024-10-15 07:11:40 -0500 Rating Details
2024-10-15 07:08:03 -0500 Rating Details
2024-10-15 06:26:19 -0500 Rating Details
2024-10-15 04:36:30 -0500 Rating Details
2024-10-15 04:05:41 -0500 Rating Details
2024-10-15 02:21:57 -0500 Rating Details
2024-10-15 02:14:18 -0500 Rating Details
2024-10-15 02:02:14 -0500 Rating Details
2024-10-15 01:37:12 -0500 Rating Details
2024-10-15 00:48:51 -0500 Rating Details
2024-10-14 23:47:37 -0500 Rating Details
2024-10-14 23:38:31 -0500 Rating Details
2024-10-14 22:47:07 -0500 Rating Details
2024-10-14 22:00:22 -0500 Rating Details
2024-10-14 21:45:42 -0500 Rating Details
2024-10-14 20:15:51 -0500 Rating Details
2024-10-14 20:05:46 -0500 Rating Details
2024-10-16 16:12:32 -0500 Rating Details
2024-10-15 16:40:35 -0500 Rating Details
2024-10-15 15:21:58 -0500 Rating Details
2024-10-15 14:07:33 -0500 Rating Details
2024-10-15 07:32:38 -0500 Rating Details
2024-10-15 07:00:32 -0500 Rating Details
2024-10-15 06:10:12 -0500 Rating Details
2024-10-15 06:04:45 -0500 Rating Details
2024-10-15 04:14:28 -0500 Rating Details
2024-10-15 01:42:57 -0500 Rating Details
2024-10-15 01:37:19 -0500 Rating Details
2024-10-15 00:35:48 -0500 Rating Details
2024-10-14 22:50:13 -0500 Rating Details
2024-10-14 22:15:41 -0500 Rating Details
2024-10-14 21:40:52 -0500 Rating Details
2024-10-14 21:05:31 -0500 Rating Details
2024-10-14 20:39:22 -0500 Rating Details
2024-10-14 20:10:17 -0500 Rating Details
2024-10-14 20:04:23 -0500 Rating Details